Investing.com -- 亿万富翁Ken Griffin旗下的对冲基金Citadel已对英国制药公司GlaxoSmithKline ...

The Citadel founder says that the US will lose out on international trade and the AI arms race as a result.

Hedge fund Citadel has made a £305mn bet against drugmaker GSK, the biggest short position against the company in more than a decade.

Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/106.Ckjk1Vbt.js ...

Citadel CEO Ken Griffin spoke out at the UBS Financial Services conference in Key Biscayne, Fla., on Tuesday, thanking Elon ...

日前，对冲基金Citadel（城堡投资）罕见地披露了旗下多策略基金的收益情况。数据显示，从2021年初至2024年9月，Citadel的三只主要基金合计创造了568亿美元的惊人收益 ，折合人民币约4100亿元。

(Alliance News) - Hedge fund Citadel has made a GBP305 million bet against pharmaceuticals firm GSK PLC, the biggest short position against the company in more than a decade, according to the ...

Citadel CEO Ken Griffin sent a stern warning Tuesday against the negative impact from President Donald Trump’s combative ...

Ken Griffin, founder and CEO of investment firm Citadel, said on Tuesday that U.S. President Donald Trump's tariff policy is ...

在全球金融市场瞬息万变的今天，某些机构的表现却让人瞠目结舌。近日，美国对冲基金巨头Citadel（城堡投资）披露了其旗下多策略基金的收益情况，令人震惊的是，过去近四年时间内，其三只核心基金合计创造了高达568亿美元的收益，相当于人民币约4100亿元。这个数字不仅展示了Citadel的投资能力，也引发了市场对其投资策略和未来发展的广泛关注。

Citadel多策略基金惊人业绩曝光！2月7日，据Citadel近期10亿美元债券发行招股书，这家由Ken Griffin创立的对冲基金巨头罕见地披露了其旗舰多策略基金的业绩数据。从2021年初至2023年9月，Citadel的三只主要基金Wellington、Kensington和Kensington ...

"Tariffs are what you do in the death throes of a nation," Griffin said at a conference outside Miami.